IL322951A - טריפטאמינים מותמרים בהידרוקסיאלקיל ומתוקסיאלקיל - Google Patents
טריפטאמינים מותמרים בהידרוקסיאלקיל ומתוקסיאלקילInfo
- Publication number
- IL322951A IL322951A IL322951A IL32295125A IL322951A IL 322951 A IL322951 A IL 322951A IL 322951 A IL322951 A IL 322951A IL 32295125 A IL32295125 A IL 32295125A IL 322951 A IL322951 A IL 322951A
- Authority
- IL
- Israel
- Prior art keywords
- disorder
- compound
- pharmaceutically acceptable
- solvate
- stereoisomer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363448011P | 2023-02-24 | 2023-02-24 | |
| PCT/US2024/017324 WO2024178425A1 (en) | 2023-02-24 | 2024-02-26 | Hydroxyalkyl and methoxyalkyl tryptamines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL322951A true IL322951A (he) | 2025-10-01 |
Family
ID=92501636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL322951A IL322951A (he) | 2023-02-24 | 2024-02-26 | טריפטאמינים מותמרים בהידרוקסיאלקיל ומתוקסיאלקיל |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4669316A1 (he) |
| JP (1) | JP2026508302A (he) |
| KR (1) | KR20250157396A (he) |
| CN (1) | CN121001719A (he) |
| AU (1) | AU2024225907A1 (he) |
| IL (1) | IL322951A (he) |
| MX (1) | MX2025010002A (he) |
| WO (1) | WO2024178425A1 (he) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2014293138A1 (en) * | 2013-07-23 | 2016-02-25 | Revalesio Corporation | Compositions and methods for upregulating hippocampal plasticity and hippocampus-dependent learning and memory |
| WO2022082058A1 (en) * | 2020-10-16 | 2022-04-21 | Eleusis Therapeutics Us, Inc. | Method of treatment by tryptamine alkaloids |
-
2024
- 2024-02-26 IL IL322951A patent/IL322951A/he unknown
- 2024-02-26 JP JP2025549922A patent/JP2026508302A/ja active Pending
- 2024-02-26 AU AU2024225907A patent/AU2024225907A1/en active Pending
- 2024-02-26 WO PCT/US2024/017324 patent/WO2024178425A1/en not_active Ceased
- 2024-02-26 EP EP24761137.9A patent/EP4669316A1/en active Pending
- 2024-02-26 CN CN202480027550.4A patent/CN121001719A/zh active Pending
- 2024-02-26 KR KR1020257031565A patent/KR20250157396A/ko active Pending
-
2025
- 2025-08-25 MX MX2025010002A patent/MX2025010002A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2025010002A (es) | 2026-02-03 |
| CN121001719A (zh) | 2025-11-21 |
| AU2024225907A1 (en) | 2025-09-18 |
| JP2026508302A (ja) | 2026-03-10 |
| EP4669316A1 (en) | 2025-12-31 |
| WO2024178425A1 (en) | 2024-08-29 |
| KR20250157396A (ko) | 2025-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12465578B2 (en) | Substituted alpha-ethyl phenylalkylamines | |
| US20210206771A1 (en) | Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment | |
| US20250195471A1 (en) | Asymmetric allyl tryptamines | |
| KR20190066023A (ko) | 화합물, 상기 화합물을 얻기 위한 공정, 약제학적 조성물, 상기 화합물의 용도 및 정신 장애 및/또한 수면 장애를 치료하기 위한 방법 | |
| CA3229907A1 (en) | Deuterated empathogens | |
| US20130338116A1 (en) | Compounds and methods for the treatment of pain and other diseases | |
| AU2024225907A1 (en) | Hydroxyalkyl and methoxyalkyl tryptamines | |
| US20250353808A1 (en) | 5-methoxymethyl and 5-hydroxymethyl phenethylamines | |
| WO2025137342A2 (en) | 5-carboxamido and 5-carboxyalkyl phenethylamines | |
| WO2025024400A2 (en) | Substituted tryptamines and uses thereof | |
| AU2024292749A1 (en) | Substituted ergolines | |
| WO2025217471A1 (en) | 2-hemifly phenethylamines | |
| WO2024091523A1 (en) | Conformationally restricted phenethylamine analogs | |
| AU2024229876A1 (en) | Deuterated and fluorinated empathogens | |
| KR20260027178A (ko) | 비대칭 페닐알킬아민 | |
| TW201811761A (zh) | 用於治療用途之化合物 | |
| JP2026508371A (ja) | フェニルアルキルアミンのプロドラッグ | |
| WO2025019403A2 (en) | Substituted amino-phenylmethylene-imidazolones | |
| CA3229910A1 (en) | Fluorinated empathogens | |
| AU2024328083A1 (en) | Pde 7 modulator compounds | |
| WO2019173506A1 (en) | Cyclopentaimidazolones for the treatment of cancer |